Two Sigma Securities’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,800
Closed -$2.97M 2877
2024
Q2
$2.97M Sell
12,800
-10,200
-44% -$2.22M 0.04% 541
2024
Q1
$4.96M Buy
23,000
+20,400
+785% +$4.78M 0.05% 401
2023
Q4
$673K Sell
2,600
-1,900
-42% -$467K 0.01% 1323
2023
Q3
$1.16M Buy
4,500
+3,000
+200% +$802K 0.01% 948
2023
Q2
$427K Buy
+1,500
New +$447K 0.01% 1554
2022
Q3
Sell
-20,800
Closed -$4.24M 2609
2022
Q2
$4.24M Buy
20,800
+11,900
+134% +$2.43M 0.15% 149
2022
Q1
$1.87M Buy
+8,900
New +$1.94M 0.07% 369
2021
Q1
Sell
-2,600
Closed -$637K 905
2020
Q4
$637K Buy
2,600
+1,200
+86% +$310K 0.02% 580
2020
Q3
$397K Sell
1,400
-14,700
-91% -$4.1M 0.01% 718
2020
Q2
$4.31M Buy
16,100
+15,100
+1,510% +$4.54M 0.1% 113
2020
Q1
$316K Sell
1,000
-16,000
-94% -$4.86M 0.01% 825
2019
Q4
$5.04M Sell
17,000
-800
-4% -$222K 0.03% 394
2019
Q3
$4.14M Buy
17,800
+100
+0.6% +$23.3K 0.04% 361
2019
Q2
$4.14M Buy
17,700
+16,400
+1,262% +$3.79M 0.04% 270
2019
Q1
$307K Sell
1,300
-4,700
-78% -$1.48M ﹤0.01% 1177
2018
Q4
$1.81M Sell
6,000
-36,900
-86% -$11.8M 0.02% 403
2018
Q3
$15.2M Buy
42,900
+8,800
+26% +$3.03M 0.1% 136
2018
Q2
$9.9M Buy
34,100
+8,700
+34% +$2.45M 0.05% 279
2018
Q1
$6.96M Buy
+25,400
New +$7.88M 0.04% 378

Other funds holding BIIB

Two Sigma Securities's BIIB Position: Q2 2026 in Review

Two Sigma Securities sold out of Biogen (BIIB) in Q2 2026, closing a stake of 1,335 shares — an estimated $245K sold.

Two Sigma Securities first reported a position in BIIB in Q4 2015 and held it in 23 quarters. The position peaked at $2.49M in Q3 2018. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Two Sigma Securities reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 1,335 Biogen shares in Q2 2026, an estimated $245K.
  • Two Sigma Securities first reported a position in Biogen in Q4 2015 and held it in 23 quarters.
  • Two Sigma Securities's Biogen position peaked at $2.49M in Q3 2018.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.